Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Gottlieb
J Cuttner

Cancer

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer|July 1, 1978
Central nervous system involvement at presentation in the chronic phase of chronic myelogenous leukemia in childhoodR J Meyer, J Cuttner
Cancer|April 1, 1979
Intracerebral involvement in Hodgkin's disease: a report of 6 cases and review of the literatureJ Cuttner, R Meyer, Y P Huang
Cancer|October 1, 1978
Phase I study with neocarzinostatin: tolerance to two hour infusion and continuous infusionT Ohnuma, C Nogeire, J Cuttner, et al.
Cancer|January 1, 1981
The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B StudyH H Hansen, O S Selawry, T F Pajak, et al.
Cancer|January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, L A Leone, et al.
Cancer|November 1, 1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Cancer|November 1, 1975
Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemiaR W Carey, M Ribas-Mundo, R R Ellison, et al.
Cancer|February 1, 1978
Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapseF H Kung, W L Nythan, J Cuttner, et al.
Cancer|August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.
Cancer|January 1, 1979
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, O Glidewell, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer|July 1, 1978
Central nervous system involvement at presentation in the chronic phase of chronic myelogenous leukemia in childhoodR J Meyer, J Cuttner
Cancer|April 1, 1979
Intracerebral involvement in Hodgkin's disease: a report of 6 cases and review of the literatureJ Cuttner, R Meyer, Y P Huang
Cancer|October 1, 1978
Phase I study with neocarzinostatin: tolerance to two hour infusion and continuous infusionT Ohnuma, C Nogeire, J Cuttner, et al.
Cancer|January 1, 1981
The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B StudyH H Hansen, O S Selawry, T F Pajak, et al.
Cancer|January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, L A Leone, et al.
Cancer|November 1, 1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.
Cancer|November 1, 1975
Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemiaR W Carey, M Ribas-Mundo, R R Ellison, et al.
Cancer|February 1, 1978
Vincristine, prednisone and L-asparaginase in the induction of remission in children with acute lymphoblastic leukemia following relapseF H Kung, W L Nythan, J Cuttner, et al.
Cancer|August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.
Cancer|January 1, 1979
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, O Glidewell, et al.
Pageof 1